Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Harvoni

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Harvoni was produced by Bristol-Myers Squibb.

Gilead must pay just $200m for hep C patents, says jury

Gilead must pay just $200m for hep C patents, says jury Merck &Co awarded a 4% royalty rate on sales of Sovaldi and Harvoni. ... Merck had been pushing for a 10% royalty rate on the $20.7bn Gilead had made from sales of two sofosbuvir-based drugs - Sovaldi and Harvoni - between 2013 and 2015, after

Merck & Co wins hepatitis C patent dispute with Gilead

Merck & Co wins hepatitis C patent dispute with Gilead The jury in the lawsuit upheld Merck's claim that Gilead's sofosbuvir - which features in its massive-selling Sovaldi and Harvoni HCV drugs - infringes two patents it holds alongside Ionis ... Gilead is also in the throes of a lawsuit with AbbVie, which

Harvoni cleared for broader use in hepatitis C

Harvoni cleared for broader use in hepatitis C and Merck &Co's recently-approved Zepatier (elbasvir/grazoprevir), which has undercut Harvoni on price. ... The company is also hoping to launch a follow-up to Harvoni, which covers a broader range of HCV genotypes and should extend the franchise.

The big picture

The big picture They actually went out and did two separate economic evaluations and determined that Sovaldi and its close cousin, Harvoni are cost-effective.

Merck & Co's oral hepatitis C therapy approved in US

Merck & Co's oral hepatitis C therapy approved in US The undisputed market leader at the moment is Gilead Sciences with its Harvoni (sofosbuvir/ledipasvir) combination and single-agent product Sovaldi (sofosbuvir), with AbbVie also pressing for market share with its ... For example, at undiscounted prices

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...
Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...

Infographics